Al-Mterin, M., Murshed, K., & Elkord, E. (2022). PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients. Cancer Immunology, Immunotherapy, https://doi.org/10.1007/s00262-022-03337-8